CLINICAL_TRIALS
trial_result
· 2022-02-08
Clinical Trial Update: Pivotal Study to Assess the Safety and Effectiveness of the iTind Device [NA]
Summary
A pivotal study evaluating the safety and effectiveness of the iTind device for benign prostatic hyperplasia has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medi-Tate Ltd. | Conditions: Benign Prostate Hyperplasia | NA | Status: COMPLETED | Results posted: 2022-02-08